News Room

TechnoPhage Announces Application of TP-102 Product in Two Compassionate Use Cases

12 Dez 2022 | Press release

TechnoPhage announced that it has provided TP-102, developed for the treatment of infected diabetic foot ulcers, for two compassionate use cases,...

7 Dez 2022 | Careers

TechnoPhage is currently looking for a Technician to join our GMP production team. We require academic degree in science or technical course...

25 Nov 2022 | News

This year Technophage has been featured in the Portuguese edition of The Business Year. The publication was based on more than 130 face-to-face...

23 Nov 2022 | Careers

TechnoPhage is currently looking for a new Financial Controller with a degree in Economics, Finance or related area, and at least 7 years of...

23 Set 2022 | Press release

TechnoPhage announced the spin-off of T-Oncology AG, which will focus on the development of Antibody Drug Conjugates (ADCs), based on the...